Fair Value Calculator Fair Value Calculator
EN DE

NAVODAYENT (NAVODAYENT) Fair Value & Analysis

IN · Market cap ₹43.9M

N NAVODAYENT NAVODAYENT · BSE
Price₹5.69
Fair Value₹6.09
Upside+7.0%
Quality54/100
Watch NAVODAYENT for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹5.24 – ₹7.41

Fair value as of: Jul 5, 2026

From 20 valuation models · updated today

Price vs Fair Value (12 months)

₹5.69 ₹5.69 Fair Value ₹6.09 Jul 2025 Jul 2026

12‑month range ₹5.69 – ₹5.69 · fair‑value band ₹5.24 – ₹7.41 · the ₹5.69 price screens below the ₹6.09 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

NAVODAYENT (NAVODAYENT) currently trades at ₹5.69, while our model-based Fair Value estimate is ₹6.09 — implying the stock looks roughly 7.0% undervalued today. We read business quality at 54/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, NAVODAYENT generated revenue of ₹87.7M at a net margin of 32.9%. Revenue declined 76.6% year over year. It earns a return on equity of 32.9%. The stock trades on a trailing P/E of 1.7. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹5.24 (bear case) to ₹7.41 (bull case); at ₹5.69, the current price sits within that range. The share trades near its 52-week high, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹87.7M
Revenue growth (YoY) -76.6%
Net margin 32.9%
Return on equity 32.9%
Free cash flow ₹97.0K FY2024
P/E ratio 1.7
More key figures
Operating margin 5.4%
EPS (TTM) ₹3.41
EPS growth (YoY) -74.9%

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2024 · reported fiscal years

NAVODAYENT reported revenue of ₹114M in FY2024 versus ₹263M in FY2021, a compound −24.3%/yr. Reported net income was ₹2.9M in FY2024, compounding −7.1%/yr from FY2021.

Revenue −24.3%/yr
FY21 ₹263M
FY22 ₹455M
FY23 ₹125M
FY24 ₹114M
Net income −7.1%/yr
FY21 ₹3.6M
FY22 ₹4.4M
FY23 ₹1.6M
FY24 ₹2.9M

Is NAVODAYENT fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "NAVODAYENT Fair Value". https://www.fairvalue-calculator.com/stock/NAVODAYENT

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is NAVODAYENT (NAVODAYENT) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹6.09 versus a price of ₹5.69 — about +7% (undervalued). Model-based estimate, not financial advice.
What is the fair value of NAVODAYENT?
Our model-based fair value for NAVODAYENT is ₹6.09 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹5.69.
What is the quality score of NAVODAYENT?
NAVODAYENT has a Quality Score of 54/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of NAVODAYENT (NAVODAYENT)?
NAVODAYENT reported trailing-twelve-month revenue of about ₹87.7M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of NAVODAYENT?
The net profit margin of NAVODAYENT is about 32.9%, meaning it keeps roughly 32.9% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.